Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 3, 2015Seminars in Thrombosis and Hemostasis

Quality and Safety Issues of Direct Oral Anticoagulants in the Emergency Department

View Full Paper
Ask AI
Bookmark
Share

Key result

The provided text is a journal masthead and contains no clinical study data.

Population

Patients with atrial fibrillation and venous thromboembolism taking direct oral anticoagulants presenting to…

Design

Review

Authors

MBMario BenattiUniversity of ParmaLBLaura BonfantiUniversity of ParmaGiuseppe LippiGiuseppe LippiUniversità Cattolica del Sacro Cuore

Discussion

Loading...

Member takes

Implication

No clinical data presented; leaves open questions on DOAC reversal and monitoring in emergencies.

Structured PICO

P
Population
Patients with atrial fibrillation and venous thromboembolism taking direct oral anticoagulants (DOACs) presenting to the emergency department
I
Intervention
Direct oral anticoagulants (DOACs)

DOACs offer a favorable bleeding profile compared to traditional anticoagulants in the emergency setting, though challenges remain regarding reversal agents and laboratory monitoring.

Cite This Study

Benatti et al. (2015) studied this question. The provided text is a journal masthead and contains no clinical study data.

synapsesocial.com/papers/6a7c5ee287fbbe073d26bcf2https://doi.org/10.1055/s-0035-1549090

Topics

Anticoagulation in AF
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Importance of Enzyme Inhibition Kinetics for the Effect of Thrombin Inhibitors in a Rat Model of Arterial Thrombosis1997 · 114 citations
  2. 2Effects of Melagatran, a New Low-molecular-weight Thrombin Inhibitor, on Thrombin and Fibrinolytic Enzymes1998 · 209 citations